Neurocrine Biosciences Financials

Values in thousands	2024-09-30	2024-06-30	2024-03-31	2023-12-31
Revenue	$622,100	$590,200	$515,299	$515,200
Gross Profit	614,100	574,600	502,499	506,700
EBITDA	191,300	155,200	111,500	156,000
EBIT	184,800	147,900	105,300	150,300
Net Income	129,800	65,000	43,400	147,700
Net Change In Cash	622,100	590,200	515,299	515,200
Free Cash Flow	149,900	52,999	119,100	118,100
Cash	349,100	139,700	396,300	251,100
Basic Shares	104,300	103,900	103,600	102,300

Values in thousands	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Revenue	$1,887,100	$1,488,700	$1,133,500	$1,045,900
Gross Profit	1,847,400	1,465,500	1,119,200	1,035,800
EBITDA	358,000	264,600	218,700	336,100
EBIT	336,700	249,000	207,800	327,500
Net Income	249,700	154,500	89,600	407,300
Net Change In Cash	1,887,100	1,488,700	1,133,500	1,045,900
Cost of Revenue		-72,000	153,700	74,800
Free Cash Flow	361,600	322,900	233,100	217,600
Cash	251,100	262,900	340,800	801,000
Basic Shares	101,000	98,900	97,900	97,800